Profil
Jan Nilsson currently works at Annexin Pharmaceuticals AB, as Chairman from 2024, CCRM Nordic AB, as Chairman, CanImGuide Therapeutics AB, as Non-Executive Director, Panion Animal Health AB, as Director from 2019, Urbicum Ledningskonsult AB, as Director, CarryGenes Therapeutics AB, as Director, and Immodulate Pharma AB, as Director.
Mr. Nilsson also formerly worked at Promore Pharma AB, as Chief Executive Officer & Director from 2011 to 2013, CombiGene AB, as Chief Executive Officer & Director, Abliva AB, as Chief Operating Officer in 2016, and Pergamum AB, as Chief Commercial Officer.
Mr. Nilsson received his Masters Business Admin degree from the University of Uppsala and graduate degree from the University of Gothenburg.
Postes actifs de Jan Nilsson
| Sociétés | Poste | Début |
|---|---|---|
| ANNEXIN PHARMACEUTICALS AB | Président | 01/01/2024 |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Directeur/Membre du Conseil | - |
Urbicum Ledningskonsult AB | Directeur/Membre du Conseil | - |
CarryGenes Therapeutics AB
CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology | Directeur/Membre du Conseil | - |
Immodulate Pharma AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Jan Nilsson
| Sociétés | Poste | Fin |
|---|---|---|
Panion Animal Health AB
Panion Animal Health AB BiotechnologyHealth Technology Develops gene therapy for treatment of dogs | Directeur/Membre du Conseil | 08/08/2025 |
| COMBIGENE AB | Directeur Général | 01/09/2023 |
| ABLIVA AB | Directeur Général | 14/03/2016 |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Develops therapeutic peptides for the bioactive would care market | Directeur Général | 01/01/2013 |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Jan Nilsson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Abliva AB
Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Develops therapeutic peptides for the bioactive would care market | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products based on therapeutic peptides | Health Technology |
CombiGene AB
CombiGene AB Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy for treatment of neurological and psychiatric disorders | Health Technology |
Annexin Pharmaceuticals AB
Annexin Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures drugs for cardiovascular diseases | Health Technology |
Panion Animal Health AB
Panion Animal Health AB BiotechnologyHealth Technology Develops gene therapy for treatment of dogs | Health Technology |
Urbicum Ledningskonsult AB | |
CarryGenes Therapeutics AB
CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology | Commercial Services |
Immodulate Pharma AB |
















